PL2841426T3 - Przeciwbakteryjne pochodne chinoliny - Google Patents

Przeciwbakteryjne pochodne chinoliny

Info

Publication number
PL2841426T3
PL2841426T3 PL13720875T PL13720875T PL2841426T3 PL 2841426 T3 PL2841426 T3 PL 2841426T3 PL 13720875 T PL13720875 T PL 13720875T PL 13720875 T PL13720875 T PL 13720875T PL 2841426 T3 PL2841426 T3 PL 2841426T3
Authority
PL
Poland
Prior art keywords
quinoline derivatives
antibacterial quinoline
antibacterial
derivatives
quinoline
Prior art date
Application number
PL13720875T
Other languages
English (en)
Polish (pl)
Inventor
Jerôme Emile Georges Guillemont
Magali Madeleine Simone Motte
David Francis Alain Lançois
Sébastien Robert Gaston Thomas
Wendy Mia Albert Balemans
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of PL2841426T3 publication Critical patent/PL2841426T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL13720875T 2012-04-27 2013-04-26 Przeciwbakteryjne pochodne chinoliny PL2841426T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12165882 2012-04-27

Publications (1)

Publication Number Publication Date
PL2841426T3 true PL2841426T3 (pl) 2017-03-31

Family

ID=48325651

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13720875T PL2841426T3 (pl) 2012-04-27 2013-04-26 Przeciwbakteryjne pochodne chinoliny

Country Status (15)

Country Link
US (1) US9617244B2 (OSRAM)
EP (1) EP2841426B1 (OSRAM)
JP (1) JP6153603B2 (OSRAM)
KR (1) KR102110366B1 (OSRAM)
CN (1) CN104254528B (OSRAM)
AU (1) AU2013254670B2 (OSRAM)
CA (1) CA2869453C (OSRAM)
DK (1) DK2841426T3 (OSRAM)
EA (1) EA038350B1 (OSRAM)
ES (1) ES2607879T3 (OSRAM)
IN (1) IN2014MN02358A (OSRAM)
MX (1) MX358506B (OSRAM)
PL (1) PL2841426T3 (OSRAM)
PT (1) PT2841426T (OSRAM)
WO (1) WO2013160431A1 (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2841425T3 (en) * 2012-04-27 2016-06-27 Janssen Pharmaceutica Nv ANTIBACTERIAL QUINOLIN DERIVATIVES
WO2018048882A1 (en) 2016-09-06 2018-03-15 The Research Foundation For The State University Of New York Positron imaging tomography imaging agent composition and method for bacterial infection
KR20240161147A (ko) 2022-03-14 2024-11-12 슬랩 파마슈티컬스 엘엘씨 다중 사이클릭 화합물

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998018326A1 (en) 1996-10-28 1998-05-07 Department Of The Army, U.S. Government Compounds, compositions and methods for treating antibiotic-resistant infections
US6103905A (en) 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
GB0118238D0 (en) * 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
DK2301544T3 (da) 2002-07-25 2013-01-02 Janssen Pharmaceutica Nv Quinolinderivater som mellemprodukter til mykobakterielle inhibitorer
CN1909907B (zh) 2004-01-23 2010-06-23 詹森药业有限公司 喹啉衍生物及其在制备分枝杆菌抑制剂中的用途
WO2005070924A1 (en) * 2004-01-23 2005-08-04 Janssen Pharmaceutica N.V. Substituted quinolines and their use as mycobacterial inhibitors
NZ547614A (en) 2004-01-29 2009-04-30 Janssen Pharmaceutica Nv Quinoline derivatives for use as mycobacterial inhibitors
DE602005005810T2 (de) 2004-05-28 2009-04-09 Janssen Pharmaceutica N.V. Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen
WO2005123081A2 (en) 2004-06-22 2005-12-29 Janssen Pharmaceutica N.V. (2-benzyl-4-{4-[1-(tetrahydrofuran-3-carbonyl)-pyrrolidin-3-yl]-piperazin-1-yl}-piperidin-1-yl)-(3,5-trifluoromethyl-phenyl))-methanone for the treatment of schizophrenia
RS56357B1 (sr) 2004-09-28 2017-12-29 Janssen Pharmaceutica Nv Vezujući domen bakterijske atp sintaze
EE05394B1 (et) 2004-12-24 2011-04-15 Janssen Pharmaceutica N.V. Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis
EE05697B1 (et) 2005-06-08 2014-02-17 Janssen Pharmaceutica N.V. Kinoliini derivaadid kui antibakteriaalsed toimeained
PL1898909T3 (pl) 2005-06-28 2017-03-31 Janssen Pharmaceutica Nv Pochodne chinoliny jako środki przeciwbakteryjne
JO3270B1 (ar) 2005-06-28 2018-09-16 Janssen Pharmaceutica Nv مشتقات كوينولين بصفة عوامل مضادة للبكتيريا
JO2752B1 (en) 2005-06-28 2014-03-15 شركة جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
JO3077B1 (ar) 2005-07-28 2017-03-15 Janssen Pharmaceutica Nv مشتقات كوينولين مضادة للبكتيريا
JO2855B1 (en) 2005-08-03 2015-03-15 شركة جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
JO2952B1 (en) 2005-08-03 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline derivatives acting as antibacterial agents
JO2837B1 (en) 2005-08-03 2014-09-15 جانسن فارمسيتكا ان في Quinoline derivatives acting as antibacterial agents
JO2684B1 (en) 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان في Quinoline antibacterial derivatives
JO2683B1 (en) 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO3271B1 (ar) 2006-12-06 2018-09-16 Janssen Pharmaceutica Nv مشتقات الكوينولين المضادة للجراثيم
JO2725B1 (en) 2006-12-06 2013-09-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
JO2685B1 (en) 2006-12-06 2013-03-03 جانسين فارماسوتيكا ان في Quinoline antibacterial derivatives
JO2970B1 (en) 2006-12-06 2016-03-15 جانسين فارماسوتيكا ان. في Quinoline antibacterial derivatives
WO2009091324A1 (en) * 2008-01-14 2009-07-23 Jyoti Chattopadhyaya Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents
DK2841425T3 (en) * 2012-04-27 2016-06-27 Janssen Pharmaceutica Nv ANTIBACTERIAL QUINOLIN DERIVATIVES

Also Published As

Publication number Publication date
EA201491971A1 (ru) 2015-02-27
CA2869453A1 (en) 2013-10-31
EP2841426A1 (en) 2015-03-04
CN104254528B (zh) 2017-06-06
CA2869453C (en) 2021-03-02
JP2015514795A (ja) 2015-05-21
JP6153603B2 (ja) 2017-06-28
EP2841426B1 (en) 2016-09-28
AU2013254670B2 (en) 2017-03-30
AU2013254670A1 (en) 2014-10-16
PT2841426T (pt) 2016-11-23
WO2013160431A1 (en) 2013-10-31
EA038350B1 (ru) 2021-08-12
HK1201520A1 (en) 2015-09-04
US20150051244A1 (en) 2015-02-19
MX358506B (es) 2018-08-22
KR20150013148A (ko) 2015-02-04
ES2607879T3 (es) 2017-04-04
KR102110366B1 (ko) 2020-05-14
DK2841426T3 (en) 2017-01-09
IN2014MN02358A (OSRAM) 2015-08-14
CN104254528A (zh) 2014-12-31
MX2014013055A (es) 2014-12-10
US9617244B2 (en) 2017-04-11

Similar Documents

Publication Publication Date Title
IL239109B (en) New quinolone derivatives
ZA201600514B (en) Quinoline derivative
ZA201409422B (en) Benzimidazole-proline derivatives
ZA201408876B (en) Pyrrolotriazinone derivatives
EP2828257A4 (en) ANTIBACTERIAL COMPOUNDS
ZA201502175B (en) Oxazolidin-2-one-pyrimidine derivatives
IL236295A (en) The history of indanesulfamide
PL2841425T3 (pl) Antybakteryjne pochodne chinoliny
ZA201405108B (en) Substituted phenylazole derivative
GB201206384D0 (en) Antibacterial drug derivatives
PL2873660T3 (pl) Pochodna indolokarboksyamidu
PL2841426T3 (pl) Przeciwbakteryjne pochodne chinoliny
ZA201501640B (en) Tricyclic tetrahydroquinoline antibacterial agents
SG11201504873RA (en) Antibacterial compounds
IL239207A0 (en) Antibacterial compounds
GB201206385D0 (en) Antibacterial drug derivatives
GB201206383D0 (en) Antibacterial drug derivatives
GB201119961D0 (en) Antibacterial derivatives
GB201119958D0 (en) Antibacterial derivatives